Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

Malignant pleural mesothelioma is a notoriously chemoresistant tumour. However, a recent single institution study showed an impressive activity of gemcitabine and cisplatin. Our aim is to investigate the efficacy and toxicity of a gemcitabine and cisplatin combination in selected and chemo-naive pat...

Descripción completa

Detalles Bibliográficos
Autores principales: van Haarst, J M W, Baas, P, Manegold, C h, Schouwink, J H, Burgers, J A, de Bruin, H G, Mooi, W J, van Klaveren, R J, de Jonge, M J A, van Meerbeeck, J P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375227/
https://www.ncbi.nlm.nih.gov/pubmed/11875695
http://dx.doi.org/10.1038/sj.bjc.6600118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375227/
https://www.ncbi.nlm.nih.gov/pubmed/11875695
http://dx.doi.org/10.1038/sj.bjc.6600118

Ejemplares similares